Omega Diagnostics Group PLC Result of Open Offer (2762L)
July 17 2017 - 8:17AM
UK Regulatory
TIDMODX
RNS Number : 2762L
Omega Diagnostics Group PLC
17 July 2017
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF EU REGULATION 596/2014
17 July 2017
Omega Diagnostics Group plc
Result of Open Offer
On 30 June 2017, Omega announced details of a Placing,
Subscription and Open Offer to raise gross proceeds of
approximately GBP3.6 million through the issue of up to 20,007,003
New Ordinary Shares at a price of 18 pence per share, with
13,116,881 shares subject to the Placing, 1,166,666 shares subject
to the Subscription and up to a further 5,723,456 shares to be
issued through the Open Offer.
The Open Offer closed for acceptances at 11.00 a.m. on 17 July
2017. Omega is pleased to announce that it has received valid
applications under the Open Offer, including those received under
the Excess Application Facility, in respect of 3,854,844 Open Offer
Shares from Qualifying Shareholders. This represents approximately
67.4 per cent. of the Open Offer Shares. Qualifying Shareholders
who have validly applied for Open Offer Shares and Excess Shares
will receive their application in full.
The Placing, Subscription and Open Offer remain conditional,
inter alia, upon the Resolutions being passed at the General
Meeting to be held at 10.00 a.m. on 18 July 2017 and Admission.
Omega expects to announce the results of the General Meeting as
soon as practicable on 18 July 2017 after the meeting concludes. It
is expected that Admission will become effective on 19 July
2017.
Capitalised terms not otherwise defined in the text of this
announcement have the meanings given to them in the Company's
circular dated 30 June 2017.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030
Andrew Shepherd, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group Finance
Director
Jag Grewal, Group Sales and Marketing
Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/James Thompson (Corporate
Finance)
Mia Gardner (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROIRRMJTMBBBBAR
(END) Dow Jones Newswires
July 17, 2017 09:17 ET (13:17 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024